The patient's safety and access to experimental drugs after the termination of clinical trials: regulations and trends

European Journal of Clinical Pharmacology
Ricardo E da SilvaMaria R C G Novaes

Abstract

Participants' rights and safety must be guaranteed not only while a clinical trial is being conducted but also when a clinical trial finishes. The criteria for post-trial access to experimental drugs, however, are unclear in various countries. The objectives of this study were (i) to ascertain if there were regulations or guidelines related to patients' access to drugs after the end of clinical trials in the countries selected in the study and (ii) to analyze trends in post-trial access in countries classified by their level of economic development. This study is a retrospective review. The data are from the records of clinical trials from 2014 registered in the World Health Organization's International Clinical Trials Registry Platform (ICTRP) database. Among the countries selected, provision of drugs post-trial is mandatory only in Argentina, Brazil, Chile, Finland, and Peru. The plans for post-trial access tend to be more present in low- and middle-income and upper middle-income countries, in comparison with high-income countries. Studies involving vulnerable populations are 2.53 times more likely to have plans for post-trial access than studies which do not. The guaranteeing of post-trial access remains mandatory in few cou...Continue Reading

References

Sep 1, 2004·Lancet·Patrina H Y CaldwellJonathan C Craig
Sep 12, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Max S ManoLissandra Dal Lago
Apr 7, 2009·Nature Reviews. Gastroenterology & Hepatology·Stephen B Hanauer
Jul 18, 2009·American Journal of Public Health·Seema ShahChristine Grady
Feb 12, 2010·American Journal of Public Health·Angelica P HerreraArmin D Weinberg
Aug 31, 2010·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·A Aitsi-Selmi, H Barratt
Jun 22, 2012·PLoS Medicine·Trudie Lang, Sisira Siribaddana
Jul 14, 2012·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Daniel Wei L Wang, Octavio Luiz Motta Ferraz
Mar 1, 2014·Nature Reviews. Drug Discovery·Paul K DrainIngrid V Bassett
Jul 6, 2014·BMJ : British Medical Journal·Rafael Dal-RéDavid Wendler
Nov 8, 2014·Bulletin of the World Health Organization·Ahmed Ehsanur RahmanUNKNOWN Persistent Diarrhoea Research Group
Dec 18, 2014·PloS One·Trevor A Richter
Dec 23, 2016·Gynecologic Oncology Reports·Surbhi GroverDavid Gaffney
Feb 9, 2017·Health Research Policy and Systems·Dearbhail Bracken-RocheEric Racine
Apr 7, 2017·Journal of Paediatrics and Child Health·Pathma D JosephJonathan C Craig

❮ Previous
Next ❯

Citations

Jun 4, 2019·International Journal for Equity in Health·Roberto IunesAugusto Afonso Guerra Junior

❮ Previous
Next ❯

Methods Mentioned

BETA
medical procedure

Software Mentioned

Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.